Health Promotion & Development
Dr. Schmella’s research program investigates the genomic underpinnings of preeclampsia, including the endolgin pathway's role in preeclampsia development. She also is interested in exploring the genomic/epigenomic underpinnings of additional pregnancy phenotypes characterized by maternal vascular maladaptation to pregnancy (e.g., utero-placental malperfusion lesions) and how these phenotypes are linked to the development of later life cardiovascular disease.
NUR 1680: Introduction to Genetics & Molecular Therapeutics
Dr. Schemella is a member of the American Society for Human Genetics; the Association of Women's Health, Obstetrics, and Neonatal Nurses (AWHONN); the International Society of Nurses in Genetics (ISONG); Sigma Theta Tau International Honor Society of Nursing, and the Society for Reproductive Investigation. She was part of the conference planning committee for the AWHONN 2015 Pennsylvania State Conference "Bridging the Gap: A Health Care Update About Women and Newborns." Dr. Schemella also has co-chaired Sigma Theta Tau's Eta Chapter Scholar's Night and served on their Research Award Grant Review Committee. Dr. Schmella is also part of the congress planning committee for ISONG’s annual congress.